Blonder Tongue Laboratories, Inc.
BDRL
$0.06
$0.000.00%
OTC PK
| 12/31/2022 | 09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | |
|---|---|---|---|---|---|
| Revenue | 5.28M | 5.26M | 4.23M | 3.34M | 3.99M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.28M | 5.26M | 4.23M | 3.34M | 3.99M |
| Cost of Revenue | 3.22M | 3.85M | 3.17M | 2.40M | 2.62M |
| Gross Profit | 2.06M | 1.41M | 1.06M | 939.00K | 1.37M |
| SG&A Expenses | 1.37M | 1.50M | 1.52M | 1.42M | 1.48M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | 1.80M |
| Total Operating Expenses | 4.95M | 5.74M | 5.20M | 4.36M | 6.57M |
| Operating Income | 326.00K | -475.00K | -962.00K | -1.02M | -2.58M |
| Income Before Tax | 90.00K | -703.00K | -1.15M | -1.15M | -912.00K |
| Income Tax Expenses | -- | -- | -- | -- | 15.00K |
| Earnings from Continuing Operations | 90.00K | -703.00K | -1.15M | -1.15M | -927.00K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 90.00K | -703.00K | -1.15M | -1.15M | -927.00K |
| EBIT | 326.00K | -475.00K | -962.00K | -1.02M | -2.58M |
| EBITDA | 348.00K | -453.00K | -936.00K | -966.00K | -2.50M |
| EPS Basic | 0.01 | -0.05 | -0.09 | -0.09 | -0.07 |
| Normalized Basic EPS | 0.00 | -0.03 | -0.05 | -0.05 | -0.13 |
| EPS Diluted | 0.01 | -0.05 | -0.09 | -0.09 | -0.09 |
| Normalized Diluted EPS | 0.00 | -0.03 | -0.05 | -0.05 | -0.13 |
| Average Basic Shares Outstanding | 13.35M | 13.33M | 13.32M | 13.13M | 12.74M |
| Average Diluted Shares Outstanding | 13.35M | 13.33M | 13.32M | 13.13M | 12.74M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |